Search results

Page title matches

• Tumor necrosis factor-alpha
  In [[medicine]], '''tumor necrosis factor-alpha''' is a "serum glycoprotein produced by activated macrophages and other mam
  8 KB (1,138 words) - 02:03, 4 November 2010
• Tumor necrosis factor-alpha/Definition
  151 bytes (21 words) - 21:14, 26 June 2010
• Tumor necrosis factor-alpha/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Tumor necrosis factor-alpha]]. Needs checking by a human.
  659 bytes (81 words) - 21:07, 11 January 2010

Page text matches

• Cytokines/Related Articles
  {{r|Tumor necrosis factor-alpha}}
  191 bytes (21 words) - 03:37, 3 January 2010
• Immunology/Related Articles
  {{r|Tumor necrosis factor-alpha}}
  460 bytes (52 words) - 13:57, 16 October 2008
• Disease modifying anti-rheumatic drugs/Definition
  ...nicillamine]], and [[monoclonal antibody|monoclonal antibodies]] against [[tumor necrosis factor-alpha]] and other immunochemicals
  422 bytes (46 words) - 19:00, 18 September 2010
• Ankylosing spondylitis
  ...n protein (etanercept - pronounced et a ner' set) blocks the activity of [[tumor necrosis factor-alpha]].<ref>{{CZMed|Etanercept}}</ref> and may help patients with ankylosing spo
  2 KB (284 words) - 13:49, 25 June 2010
• Cachexia
  ...stimulated by [[cytokines]] released by the disease process, especially [[tumor necrosis factor-alpha]], umor necrosis factor-α, IL-1b, and IL-6. The ATP-ubiquitin-protease pat
  1 KB (154 words) - 15:53, 28 June 2010
• Ankylosing spondylitis/Related Articles
  {{r|Tumor necrosis factor-alpha}}
  559 bytes (69 words) - 10:56, 11 January 2010
• Tumor necrosis factor-alpha/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Tumor necrosis factor-alpha]]. Needs checking by a human.
  659 bytes (81 words) - 21:07, 11 January 2010
• Disease modifying anti-rheumatic drugs/Related Articles
  {{r|Tumor necrosis factor-alpha blockers}}
  925 bytes (100 words) - 19:38, 18 September 2010
• Immunosuppressant/Related Articles
  {{r|Tumor necrosis factor-alpha}}
  835 bytes (102 words) - 17:24, 11 January 2010
• Immunosuppressant
  *soluble [[tumor necrosis factor-alpha]] receptor
  963 bytes (119 words) - 16:39, 5 February 2009
• Mixed connective tissue disease
  A report of two cases suggested [[tumor necrosis factor-alpha]] inhibitors could aggravate the disease. Antibodies to dual-stranded DNA,
  2 KB (301 words) - 14:46, 31 July 2010
• Churg-Strauss syndrome
  ...the "therapeutic efficacy of recombinant interferon-alpha (IFN-alpha) and tumor necrosis factor-alpha (TNF-alpha) blockade. Recent data show that, in contrast to other primary s
  2 KB (228 words) - 09:02, 5 August 2010
• Systemic lupus erythematosus/Related Articles
  {{r|Tumor necrosis factor-alpha}}
  1 KB (149 words) - 03:19, 28 December 2010
• Lymphocyte
  *[[Tumor necrosis factor-alpha]] (TNFa)
  2 KB (346 words) - 00:56, 19 August 2010
• Tumor necrosis factor-alpha
  In [[medicine]], '''tumor necrosis factor-alpha''' is a "serum glycoprotein produced by activated macrophages and other mam
  8 KB (1,138 words) - 02:03, 4 November 2010
• Hydrocortisone
  ...including [[interleukin]]s IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and [[tumor necrosis factor-alpha]] (TNF-alpha), and by suppressing humoral immunity which caused lower amoun
  4 KB (439 words) - 01:53, 29 October 2013
• Food and Drug Administration/Related Articles
  {{r|Tumor necrosis factor-alpha}}
  4 KB (505 words) - 16:36, 11 January 2010
• Behcet's syndrome
  Inhibitors of [[tumor necrosis factor-alpha]] have been of benefit, including [[etanercept]], [[infliximab]], and, with
  4 KB (495 words) - 00:40, 19 August 2010
• Antimalarial
  ...cytokines, specifically including IL-1, IL-2, IL-3, IL-4, IL-5, IL-6 and [[tumor necrosis factor-alpha]].<ref>''Practical Rheumatology'', p. 441</ref>
  4 KB (497 words) - 14:20, 9 October 2010
• Inflammatory bowel disease
  ...as well as [[methotrexate]]. Recently, a [[monoclonal antibody]] against [[tumor necrosis factor-alpha]], [[infliximab]], has come into use either independently of the aforementi
  4 KB (547 words) - 16:34, 2 August 2010
• Thalidomide
  * [[immunomodulator]] for [[tumor necrosis factor-alpha]]
  5 KB (644 words) - 02:45, 21 March 2024
• Gangrene
  ..., and neutralization of that toxin or related chemical messengers (e.g., [[tumor necrosis factor-alpha]] is appropriate.
  7 KB (936 words) - 17:11, 13 June 2010
• Steatohepatitis
  ...etected by liver biopsy, or can be suggested by elevated blood levels of [[tumor necrosis factor-alpha]] (TNF-alpha) and [[transforming growth factor]] beta (TGF-beta).<ref name=
  13 KB (1,824 words) - 20:28, 25 June 2012
• Adiposopathy
  22 KB (3,243 words) - 08:33, 17 April 2024
• Rheumatoid arthritis
  ** [[Tumor necrosis factor-alpha]] (TNFα) [[cytokine]] inhibitors<ref name="pmid17099951">{{cite journal| a
  38 KB (5,208 words) - 09:02, 1 March 2024
• Parainfluenza virus
  17 KB (2,584 words) - 00:51, 25 October 2013
• Trichomonas vaginalis
  16 KB (2,181 words) - 02:17, 17 October 2013
• Borrelia burgdorferi
  20 KB (2,900 words) - 03:34, 16 February 2010
• Chronic obstructive pulmonary disease
  [[Tumor necrosis factor-alpha]] antagonists (TNF-a) are the most recent class of medications designed to
  48 KB (6,593 words) - 11:52, 2 February 2023